S2Medical Valuation

Is S2M undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of S2M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: S2M (SEK0.01) is trading below our estimate of fair value (SEK3.82)

Significantly Below Fair Value: S2M is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for S2M?

Key metric: As S2M is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for S2M. This is calculated by dividing S2M's market cap by their current revenue.
What is S2M's PS Ratio?
PS Ratio	0.2x
Sales	SEK 10.99m
Market Cap	SEK 2.45m

S2M key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.1x
Enterprise Value/EBITDA	0.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does S2M's PS Ratio compare to its peers?

The above table shows the PS ratio for S2M vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	7.8x
BIOVIT Bio Vitos Pharma	23.6x	n/a	SEK 26.4m
BIOWKS Bio-Works Technologies	1.7x	n/a	SEK 65.5m
IMS Invent Medic Sweden	4.9x	n/a	SEK 32.9m
EVOL Evolear	0.9x	n/a	SEK 2.2m
S2M S2Medical	0.2x	n/a	SEK 2.4m

Price-To-Sales vs Peers: S2M is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (7.8x).

Price to Sales Ratio vs Industry

How does S2M's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	4.7x	17.5%
S2M S2Medical	0.2x	n/a	US$221.42k
ARJO B Arjo	0.8x	3.6%	US$808.67m
CARE Careium	0.8x	10.2%	US$62.46m

12 Companies		Estimated Growth	Market Cap
Industry Avg.	4.7x	36.6%
S2M S2Medical	0.2x	n/a	US$221.42k

No more companies

Price-To-Sales vs Industry: S2M is good value based on its Price-To-Sales Ratio (0.2x) compared to the Swedish Medical Equipment industry average (4.7x).

Price to Sales Ratio vs Fair Ratio

What is S2M's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

S2M PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate S2M's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Arcoma

SEK 144.4m

Develops, produces, and provides radiology solutions worldwide.

ARCOMA

SEK 10.95

1.4%

47.0%

Dignitana

SEK 96.7m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.20

4.3%

-45.5%

Iconovo

SEK 79.9m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.02

-1.6%

-46.3%